Olympus
Olympus Corporation, commonly referred to as Olympus, is a leading global technology company headquartered in Japan. Founded in 1919, Olympus has established itself as a key player in the medical, scientific, and imaging industries, with significant operations across Asia, Europe, and the Americas. The company is renowned for its innovative medical devices, particularly in endoscopy and surgical solutions, as well as its advanced imaging equipment, including digital cameras and microscopes. Olympus's commitment to quality and precision has positioned it as a trusted name in healthcare and imaging technology. With a rich history of milestones, including pioneering developments in optical technology, Olympus continues to excel in the market, recognised for its contributions to improving patient outcomes and enhancing visual experiences.
DitchCarbon Score
How does Olympus's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Electrical Machinery Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Olympus's score of 85 is higher than 91% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Olympus's reported carbon emissions
In 2024, Olympus Corporation reported total greenhouse gas emissions of approximately 830,202,000 kg CO2e. This includes 27,255,000 kg CO2e from Scope 1 emissions, 15,125 kg CO2e from market-based Scope 2 emissions, and a significant 787,822,000 kg CO2e from Scope 3 emissions. The Scope 3 emissions are primarily driven by purchased goods and services, which account for about 528,598,000 kg CO2e. Olympus has set ambitious climate commitments, aiming for net-zero greenhouse gas emissions across its entire value chain by FY2040, using FY2020 as the baseline. The company has established near-term targets to reduce absolute Scope 1 and 2 emissions by 70% by FY2031. Additionally, Olympus aims for 80% of its suppliers, in terms of emissions from purchased goods and services, capital goods, and upstream transportation and distribution, to have science-based targets by FY2028. Long-term, the company targets a 90% reduction in absolute Scope 1, 2, and 3 emissions by FY2040. These commitments align with the Science Based Targets initiative (SBTi) and reflect Olympus's dedication to addressing climate change within the healthcare equipment and supplies sector.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 115,289,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 24,310,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000 | 00,000 | 00,000 | 00,000 | 00,000 |
| Scope 3 | 51,404,000 | - | 00,000,000 | 00,000,000 | 00,000,000 | - | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Olympus is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
